Opus 2 Implements First 'Arbitration Room of the Future' on US Soil
September 15, 2016 11:19 ET
|
Opus 2
NEW YORK, NY--(Marketwired - Sep 15, 2016) - Opus 2 International, a worldwide litigation services and software development company, has announced the successful completion of the first fully...
Star Bulk Carriers Corp. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015
February 29, 2016 18:00 ET
|
Star Bulk Carriers Corp.
ATHENS, GREECE--(Marketwired - Feb 29, 2016) - Star Bulk Carriers Corp. (the "Company" or "Star Bulk") (NASDAQ: SBLK), a global shipping company focusing on the transportation of dry bulk cargoes,...
BioCryst Reports Fourth Quarter & Full Year 2015 Financial Results
February 23, 2016 06:50 ET
|
BioCryst Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2016 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial results for the fourth quarter and full year ended December...
BioCryst Announces Results From OPuS-2
February 08, 2016 06:00 ET
|
BioCryst Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, N.C., Feb. 08, 2016 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc., (NASDAQ:BCRX) today announced results from OPuS-2 (Oral ProphylaxiS-2), a clinical trial of...
Opus 2 Magnum 6.0 Empowers Law Firms With Firm-Wide Transcript and Case Analysis Software in a Private Cloud
February 02, 2016 09:00 ET
|
Opus 2 International
NEW YORK, NY--(Marketwired - Feb 2, 2016) - Opus 2 International (opus2.com), a worldwide litigation services and software development company, today formally released the sixth generation of its...
BioCryst Reports Third Quarter 2015 Financial Results
November 05, 2015 06:55 ET
|
BioCryst Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 5, 2015 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial results for the third quarter ended September 30, 2015.
"The...
BioCryst Announces Completion of Patient Enrollment in OPuS-2: a Clinical Trial of Avoralstat in Patients With HAE
October 08, 2015 05:59 ET
|
BioCryst Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, N.C., Oct. 8, 2015 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc., (NASDAQ:BCRX) today announced that it has completed enrollment in OPuS-2 (Oral ProphylaxiS-2), a blinded,...
Opus 2 Litigation Practices Survey Reveals That Law Firms and Corporations Poised to Reap Big Benefits by Adopting Litigation-Specific Tools and Cloud Workspaces
September 29, 2015 09:00 ET
|
Opus 2 International
SAN FRANCISCO, CA--(Marketwired - Sep 29, 2015) - Today, Opus 2 International released the results of its inaugural survey of litigation practices, examining trends in evidence management, case...
BioCryst Reports Second Quarter 2015 Financial Results
August 07, 2015 06:50 ET
|
BioCryst Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 7, 2015 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial results for the second quarter ended June 30, 2015.
"During the...
BioCryst Reports First Quarter 2015 Financial Results
May 08, 2015 06:58 ET
|
BioCryst Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, N.C., May 8, 2015 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced financial results for the first quarter ended March 31, 2015.
"We look...